William B. and Sheila Konar Professor of Psychiatry
University of Rochester School of Medicine and Dentistry
Alzheimer’s Disease Care, Research and Education Program (AD-CARE)
University of Rochester Medical Center
Monroe Community Hospital
Rochester, New York
Assistant Professor of Neurology
Brown University Alpert Medical School
Assistant Professor of Health Services, Policy & Practice
Brown University School of Public Health
Providence, Rhode Island
Associate Dean for Clinical and Community Partnerships
Professor, Nell Hodgson Woodruff School of Nursing at Emory University
Integrated Memory Care Clinic/Brain Health Center
Professor of Medicine
Associate Dean for Community Medicine
Creighton University School of Medicine
Susan P. Tyler, MEd, CMP, CHCP, CME Director, University of Cincinnati, has no conflicts of interest to disclose.
Bruce C. Gebhardt, MD, CME Reviewer-Compliance, University of Cincinnati, has no conflicts of interest to disclose.
Heather Muskopf, Program Manager, Continuing Medical Education, University of Cincinnati, has no conflicts of interest to disclose.
Kathleen Hines, Vice President, Editorial Services, MCM Education, has no conflicts of interest to disclose.
The credit providers require all faculty to disclose any planned discussion of an investigational and/or off-label use of a pharmaceutical product or device within their presentation. Participants should note that the use of products outside FDA-approved labeling should be considered experimental and are advised to consult current prescribing information for approved indications.
In this educational activity, the faculty reports that their presentation will not contain reference to investigational and/or off-label uses.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Physicians, advanced practice nurses, physician assistants, and consultant or senior care pharmacists who care for older adults.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity was developed through the joint providership of the University of Cincinnati and MCM Education.
ACCME Accreditation Support:
Please contact the University of Cincinnati Continuing Medical Education Department at firstname.lastname@example.org or call 513-558-7277.
This session is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), the University of Cincinnati, the American Society of Consultant Pharmacists, and MCM Education.
Anthony J. Jannetti, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.
Nursing Learning Outcome
After attending this session, the learner will be able to outline optimal treatment and management of Alzheimer’s disease.
The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This knowledge-based activity, ACPE UAN 0203-9999-19-034-H01-P is approved for 1.0 contact hour. Participants must view the activity in its entirety, complete the post-test (80% or higher) and evaluation to receive CPE credit. Initial Release Date: March 29, 2019, Expiration Date: March 29, 2020.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 29, 2019, through March 29, 2020:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 80% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
Concise CCO activity on selecting second-generation antipsychotics for treatment augmentation in patients with MDD and managing adverse events
Free slides from CCO and Rakesh Jain, MD, MPH: Expert insights on efficacy, role of antipsychotics in MDD, mitigating and manage adverse events
Free slides from CCO and Christoph U. Correll, MD: Expert insights on comorbidities in treatment augmentation for MDD
Expert commentary on prevention and emerging treatment strategies for the COVID-19 pandemic from CCO
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.